A framework for two-stage adaptive procedures to simultaneously test non-inferiority and superiority

Statistics in Medicine

Volumn 24, Issue 16, 2005, Pages 2439-2456

  Koyama, Tatsuki ^a   Sampson, Allan R ^b   Gleser, Leon J ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adaptive design; Conditional power; Sample size modification

Indexed keywords

ANALYTICAL ERROR; ARTICLE; CLINICAL STUDY; METHODOLOGY; SAMPLE SIZE; STATISTICAL ANALYSIS;

CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; DRUG EVALUATION; HUMANS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 23244448022     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.2118     Document Type: Article

References (16)

1. Committee for Proprietary Medicinal Products (CPMP). Points to consider on switching between superiority and non-inferiority. British Journal of Clinical Pharmacology 2001; 52:223-228.
2. Aras G. Superiority, non-inferiority, equivalence, and bioequivalence-revisited. Drug Information Journal 2001; 35:1157-1164.
3. Morikawa T, Yoshida M. A useful testing strategy in phase III trials: combined test of superiority and test of equivalence. Journal of Biopharmaceutical Statistics 1995; 5(5):297-306.
4. Marcus R, Peritz E, Gabriel KR. On closed testing procedures with special reference to ordered analysis of variance. Biometrika 1976; 63:655-660.
5. D'Agostino RB, Massaro JM, Sullivan LM. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics. Statistics in Medicine 2003; 22:169-186.
6. Liu Q, Chi GYH. On sample size and inference for two-stage adaptive designs. Biometrics 2001; 57:172-177.
7. Friede T, Kieser M. A comparison of methods for adaptive sample size adjustment. Statistics in Medicine 2001; 20:3861-3873.
8. Proschan MA, Liu Q, Hunsberger S. Practical midcourse sample size modification in clinical trials. Controlled Clinical Trials 2003; 24:4-15.
9. Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics 1994; 50:1029-1041.
10. Proschan MA, Hunsberger SA. Designed extension of studies based on conditional power. Biometrics 1995; 51:1315-1324.
11. Wang SJ, Hung HMJ, Tsong Y, Cui L. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials. Statistics in Medicine 2001; 20:1903-1912.
12. Brannath W, Bauer P, Maurer W, Posch M. Sequential tests for non-inferiority and superiority. Biometrics 2003; 59:106-114.
13. Ng TH. Issues of simultaneous tests for non-inferiority and superiority. Journal of Biopharmaceutical Statistics 2003; 13:629-639.
14. Committee for Proprietary Medicinal Products (CPMP). Points to Consider on the Choice of Non-inferiority Margin (Draft) (CPMP/EWP/2158/99). EMEA: London, 2004.
15. Gould AL. 3-Decision Rules Useful for Assessing Superiority or Equivalence. ENAR Biometrics Society. Memphis, TN, 25 March 1997.
16. Koyama T, Sampson AR, Gleser LJ. A calculus for design of two-stage adaptive procedures. Journal of the American Statistical Association 2005; 100(469):197-203.